Guidelines - Are they useful?

Epilepsia

Volumn 47, Issue SUPPL. 1, 2006, Pages 62-64

  Ben Menachem, Elinor ^a   French, Jacqueline A ^b,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antiepileptic drugs; Clinical trials; Evidence based guidelines

Indexed keywords

CARBAMAZEPINE; FELBAMATE; PHENYTOIN; TIAGABINE; VIGABATRIN; ZONISAMIDE;

ADD ON THERAPY; ALGORITHM; ANTICONVULSANT THERAPY; CLINICAL PRACTICE; CLINICAL PROTOCOL; COST BENEFIT ANALYSIS; DISEASE CLASSIFICATION; DRUG INDICATION; EPILEPSY; EVIDENCE BASED MEDICINE; FOCAL EPILEPSY; FOOD AND DRUG ADMINISTRATION; HUMAN; LENNOX GASTAUT SYNDROME; MEDICAL DECISION MAKING; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

ANTICONVULSANTS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; EPILEPSY; EVIDENCE-BASED MEDICINE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PROFESSIONAL PRACTICE; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 33749569525     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00663.x     Document Type: Review

References (4)

1. French JA, Kanner AM, Bautista J, et al. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1261-73.
2. French JA, Kanner AM, Bautista J, et al. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1252-60. Review.
3. Nice Guidelines - National Institute for Clinical Excellence www.nice.org.uk
4. Cramer J, Ben-Menachem E, French J. Treatment options for refractory epilepsy: new medications and vagal nerve stimulation. Epilepsy Res 2001;47:17-25.